富银融资(08452.HK)控股股东杉杉香港出售逾7,900万股 持股降至19.6%失控股权
富银融资股份(08452.HK)公布,公司接获控股股东杉杉香港通知,杉杉香港於今日(18日)已订立协议,出售公司合共7,905.5万股非上市外资股,相当於公司已发行股份总数之22%,其中向优科玉出售4,671.4万股,相当於公司已发行股份总数之13%;及向恒盛融诚出售公司3,234万股,相当於公司已发行股份总数之9%。
出售完成後,杉杉香港将持有公司7,044.5万股非上市外资股,相当於公司已发行股份总数约19.6%,杉杉香港及受其控制的任何公司将不再为公司的控股股东。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.